
IGF-1 LR3
Long R3 Insulin-like Growth Factor-1
Also called IGF-1 LR3, Long R3 IGF-1, long arginine 3 IGF-1
Long-acting IGF-1 that bypasses the binding proteins
IGF-1 LR3 is ordinary IGF-1 with two changes that stop it being mopped up by the proteins that normally bind it. That makes it far longer-lasting and more potent than the natural version in laboratory work. It was developed as a cell-culture reagent, has almost no human research, and carries the same blood-sugar risk as IGF-1, for longer.
A modified version of IGF-1, the growth factor that does most of the actual tissue-building work after growth hormone gives the order. The modification stops it being caught by the proteins that normally hold IGF-1 in check, so far more of it stays active for far longer. That is the selling point and the safety problem in the same sentence.
- Half-life
- About 20 to 30 hours
- Status
- Not FDA-approved
Studied in people, and well studied in preclinical models
49 papers · 1 clinical trial
What IGF-1 LR3 has been studied for
The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.
- Muscle growth
- The reason people look it up. Because it evades the binding proteins that normally hold IGF-1 in check, more of it stays active for far longer. No human trial has tested it for muscle.
- Recovery between hard sessions
- Discussed on the theory that it speeds tissue repair. There is no human trial supporting that; it is extrapolated from what IGF-1 does biologically.
Mechanism of Action
How IGF-1 LR3 works
Growth hormone does not build much tissue itself. It mostly travels to the liver and tells it to make something else: IGF-1, the growth factor that goes out and does the actual work on muscle and other tissue.
So IGF-1 is the messenger at the end of the chain. Taking it directly skips the pituitary, skips the liver, and skips every brake in between.
What LR3 changes
The body keeps IGF-1 on a tight leash. Around 98% of it circulates bound to carrier proteins, held inactive until it is needed. That binding is a control system, not an inefficiency: free IGF-1 tells cells to grow, and a permanent grow signal is not something the body allows.
LR3 is IGF-1 with two changes that stop those carrier proteins gripping it properly. The result is a version that stays free and active for hours instead of minutes.
That cuts both ways. The property that makes it potent is the removal of a brake the body installed on a growth signal.
What that means in practice
The growth instruction is not selective about which cells it reaches. That is why the standing caution around this compound concerns anything already growing that you would rather was not, and why it is one to raise with an actual doctor rather than a forum.
There is also almost no human research on this specific modified version. Most of what people cite is about ordinary IGF-1, which behaves differently precisely because it is still on the leash.
IGF-1 LR3 side effects: what studies reported
The same profile as IGF-1, stretched out. That is the important part: low blood sugar can last for hours rather than minutes.
Most commonly reported
- Low blood sugar: shakiness, sweating, sudden intense hunger, difficulty concentrating
- Injection-site reactions
- Water retention
- Tiredness
Worth keeping an eye on
- Numbness or tingling in the hands from swelling at the wrist
- Joint aching
- Because it lasts far longer than plain IGF-1, its effects persist for hours
The ones to take seriously
- Blood sugar can fall far enough to be dangerous, and hours after the injection
- It is a strong growth signal that ignores the body's normal brakes, which is the reason for the cancer caution
Dose-related findings. Blood sugar effects are dose-related, as with IGF-1.
Source: Reports outside trials; there is no clinical trial of this modified version in healthy people. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about IGF-1 LR3 belong with a licensed clinician who knows your history.
Your Genetics & IGF-1 LR3
The genes involved in how IGF-1 LR3 works
IGF-1 LR3 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.
This promoter variant has been associated with differences in baseline IGF-1 levels in population studies. It describes a baseline, not a response to IGF-1 LR3.
IGF1R · ••
Builds the receptor IGF-1 LR3 acts on. Variants have been studied for their association with IGF-1 levels, height and longevity. No study has tested whether they change response to IGF-1 LR3.
IGFBP3 · ••
The -202 A/C variant has been associated with differences in IGFBP-3 levels, the main IGF-1 carrier protein, in population studies. LR3 largely evades IGFBP-3, so any link to it is a hypothesis.
GHR · ••
The exon 3 deletion produces a shorter growth hormone receptor that some studies associated with greater growth hormone sensitivity. It acts upstream of IGF-1 and has not been studied with IGF-1 LR3.
The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.
Which of these variants do you carry?
Your report reads the DNA file you already have against this research.
Often discussed alongside
Compounds that come up next to IGF-1 LR3 in research and discussion. Each has its own page. None of this is a suggestion to combine them.

IGF-1
the natural hormone it is modified fromModerate EvidenceInsulin-like Growth Factor-1
The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.
4
Gene variants
45+
Studies
Access
Access and legal status
IGF-1 LR3 is not an FDA-approved drug. Products sold online as “research chemicals” are labelled not for human use, and FDA treats them as unapproved drugs when they are marketed for people. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.
Your DNA and IGF-1 LR3: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →
Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.
Worth knowing about IGF-1 LR3
Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.
- Prolonged low blood sugar
- IGF-1 acts on machinery shared with insulin, and LR3 stays active for hours, so the blood-sugar drop lasts longer than with plain IGF-1. Severe hypoglycaemia is a medical emergency.
- It was designed to escape the body's controls
- The binding proteins it evades exist to regulate IGF-1. Removing that regulation is exactly what makes it potent and exactly what makes it less forgiving.
Last updated · literature counts verified against PubMed on
Frequently Asked Questions
What is the difference between IGF-1 LR3 and regular IGF-1?
IGF-1 LR3 is an engineered analogue with an extended half-life and a substitution that stops IGF binding proteins from inactivating it. Native IGF-1 is mostly bound and its free form lasts minutes; LR3 stays free and active for hours, which makes it more potent in laboratory work.
Why does IGF-1 LR3 affect blood sugar?
The IGF-1 receptor shares signalling machinery with the insulin receptor, so activating it can lower blood glucose. Because LR3 stays active for hours, the drop can last longer than with natural IGF-1.
Do genes affect IGF-1 LR3 response?
No study has tested whether any genotype changes response to IGF-1 LR3. IGF1, IGF1R, IGFBP3 and GHR build the hormone, receptor and carrier proteins of the IGF system, and some of their variants have been associated with IGF-1 levels in population studies. A DNA report can show which versions you carry and what that research does and does not show.
Watch
What clinicians and researchers say about IGF-1 LR3
1 hr 30 minPeptide Expert: What Do Peptides Actually Do? (EXPLAINED) - Dr Alex TatemThe Diary of a CEO · PodcastBPC-157TB-500MOTS-c
13 minDr. Explains Peptide Stacks Used for Muscle GrowthAshley Froese · EducatorSermorelinCJC-1295Tesamorelin
19 minLearn Peptides So Fast it's UNREALAshley Froese · EducatorGHK-CuKPVThymosin Alpha-1Learn more about IGF-1 LR3
Your DNA and IGF-1 LR3
What the research says about your variants.
The report
Which IGF-1 LR3 variants do you carry?
Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.
Read my DNA, $99